Valuation: Pathkey.AI Ltd

Market Cap 21.61M 15.2M 13.64M 12.59M 11.42M 21.34M 1.44B 151M 59.96M 757M 57.04M 55.82M 2.4B P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 18.2M 12.8M 11.49M 10.61M 9.62M 17.98M 1.22B 127M 50.5M 637M 48.04M 47.01M 2.02B EV / Sales 2025
21.1x
EV / Sales 2026 1,648x
Free-Float
17.5%
Yield 2025 *
-
Yield 2026 -
1 day+6.67%
1 week-20.00%
Current month-40.74%
1 month-38.46%
3 months-48.39%
6 months-60.98%
1 week 0.02
Extreme 0.015
0.02
1 month 0.02
Extreme 0.015
0.03
Current year 0.02
Extreme 0.015
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.15
10 years 0.01
Extreme 0.014
2.4
Manager TitleAgeSince
Chief Executive Officer - 2026-05-10
Chief Tech/Sci/R&D Officer - 1994-01-16
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2025-10-20
Director/Board Member - 2025-10-20
Chairman - 2025-11-25
Change 5-day change 1-year change 3-year change Capi.($)
+6.67%-20.00%-20.00%-63.64% 14.25M
+1.53%+1.49%+26.31%+62.26% 256B
+1.35%+0.68%+8.56%+27.21% 163B
+0.32%+4.41%-18.04%+72.92% 155B
-6.29%-5.37%-58.28%-15.84% 65.3B
+0.94%+3.69%+11.52%+46.99% 52.35B
+1.47%+1.97%-12.96%-7.08% 51.93B
+0.65%-1.37%+8.51%+66.15% 50.75B
+2.29%+2.20%+24.56%+79.56% 50.04B
+2.30%+4.86%+38.67%+102.67% 46.03B
Average +1.13%-0.94%+0.88%+37.12% 89.04B
Weighted average by Cap. +0.73%+1.68%+5.52%+50.30%

Financials

2025 2026
Net sales 322K 226K 203K 188K 170K 318K 21.51M 2.25M 894K 11.28M 850K 832K 35.76M 47.63K 33.5K 30.07K 27.76K 25.18K 47.05K 3.18M 333K 132K 1.67M 126K 123K 5.29M
Net income -1.45M -1.02M -914K -844K -765K -1.43M -96.72M -10.12M -4.02M -50.7M -3.82M -3.74M -161M -3.65M -2.57M -2.31M -2.13M -1.93M -3.61M -244M -25.53M -10.14M -128M -9.64M -9.44M -406M
Net Debt -25.17K -17.7K -15.89K -14.67K -13.3K -24.86K -1.68M -176K -69.84K -881K -66.44K -65.02K -2.79M -3.41M -2.4M -2.15M -1.99M -1.8M -3.37M -228M -23.83M -9.46M -119M -9M -8.81M -379M
Projected Income Statement - Annual - Pathkey.AI Ltd
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
26-10-28 A$0.0160 +6.67% 1,642,057
26-10-27 A$0.0150 -6.25% 1,691,962
26-10-26 A$0.0160 0.00% 542,967
26-10-23 A$0.0160 -11.11% 2,036,977
26-10-22 A$0.0180 0.00% 1,409,412